You are here: Home » Current Affairs » Coronavirus » News
Problem not of coronavirus vaccine shortage but of planning: Govt
NGT does not have powers to strike down laws, says Supreme Court
Business Standard

Johnson & Johnson delays vaccine rollout in Europe amid blood clot probe

This comes amid a US probe into rare blood clots.

Coronavirus Vaccine | Coronavirus | Coronavirus Tests

AP | PTI  |  Berlin 

Johnson & Johnson's Vaccine, J&J, Coronavirus vaccine
Photo: Shutterstock

Johnson & Johnson says it is delaying the rollout of its vaccine in Europe amid a US probe into rare blood clots.

The company announced the decision Tuesday after regulators in the United States said they were recommending a pause in administration of the single-dose shot to investigate reports of potentially dangerous blood clots.

We have been reviewing these cases with European health authorities, the company said. We have made the decision to proactively delay the rollout of our vaccine in Europe.

Hundreds of thousands of doses of the vaccine were due to be shipped to Europe in the coming weeks.

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, April 13 2021. 19:49 IST